Iron Triangle Partners LP Bristol Myers Squibb CO Transaction History

Iron Triangle Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $8.66 Million - $9.81 Million	-150,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $7.91 Million - $8.76 Million	-137,710 Reduced 47.86%	150,000 $9.04 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $2.07 Million - $2.42 Million	37,710 Added 15.08%	287,710 $16.9 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $2.32 Million - $3.37 Million	-50,000 Reduced 16.67%	250,000 $13.9 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $14.8 Million - $19.3 Million	300,000 New	300,000 $19.3 Million

2,453

1.5B

29.6M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

Stay updated on Iron Triangle Partners LP with notifications on news.